Showing results (261-270 of 542) with videos related to

Sort By:
Pageof 55
Blood|October 15, 1993
High glucocorticoid receptor content of leukemic blasts is a favorable prognostic factor in childhood acute lymphoblastic leukemiaG J Kato, F F Quddus, J J Shuster, et al.
Seminars in Oncology|March 15, 2002
Preclinical and clinical studies of docetaxel and exisulind in the treatment of human lung cancerPaul A Bunn, Daniel C Chan, Keith Earle, et al.
Blood|July 1, 1990
Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group studyW M Crist, A J Carroll, J J Shuster, et al.
Blood|September 1, 1992
Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (greater than 50 chromosomes) B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group studyV M Whitehead, M J Vuchich, S J Lauer, et al.
Journal of Women'S Health (2002)|March 7, 2019
Sex Differences in Veterans' Cardiovascular HealthAlison M Whitehead, Nancy H Maher, Karen Goldstein, et al.
Journal of Integrative and Complementary Medicine|April 8, 2026
Understanding Primary Care Providers' Decisions to Recommend Complementary and Integrative Health Therapies: A Qualitative AnalysisMarlena H Shin, Michael G McGowan, Danna R Kasom, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 10, 2012
Glucocorticoid effects on changes in bone mineral density and cortical structure in childhood nephrotic syndromeAnne Tsampalieros, Pooja Gupta, Michelle R Denburg, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 28, 2025
Challenges to initiate and complete a 4-month rifapentine-moxifloxacin TB treatment regimenM E Galvis, G E Gao, M M Salerno, et al.
Plos One|September 8, 2018
Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trialStephen A Harrison, Andrea Dennis, Martine M Fiore, et al.
Chemmedchem|November 14, 2024
[<sup>18</sup>F]NP3-627, a Candidate PET Imaging Agent Targeting the NLRP3 Inflammasome in the Central Nervous SystemDavid M Whitehead, Christian Fischer, Emmanuelle Briard, et al.
Pageof 55